CN102824562B - 一种治疗吸烟型闭合性骨折的中药洗剂制备方法 - Google Patents
一种治疗吸烟型闭合性骨折的中药洗剂制备方法 Download PDFInfo
- Publication number
- CN102824562B CN102824562B CN 201210305123 CN201210305123A CN102824562B CN 102824562 B CN102824562 B CN 102824562B CN 201210305123 CN201210305123 CN 201210305123 CN 201210305123 A CN201210305123 A CN 201210305123A CN 102824562 B CN102824562 B CN 102824562B
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- chinese medicine
- radix
- herb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 208000003044 Closed Fractures Diseases 0.000 title claims abstract description 23
- 239000006210 lotion Substances 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000011282 treatment Methods 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 18
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 241000218628 Ginkgo Species 0.000 claims description 6
- 241000244155 Taenia Species 0.000 claims description 6
- 241001199012 Usta Species 0.000 claims description 6
- 229940056582 human hair preparation Drugs 0.000 claims description 6
- 235000012239 silicon dioxide Nutrition 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 2
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 2
- 244000082204 Phyllostachys viridis Species 0.000 abstract 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 2
- 239000011425 bamboo Substances 0.000 abstract 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- 241001519274 Ajuga reptans Species 0.000 abstract 1
- 241000237528 Arcidae Species 0.000 abstract 1
- 241000471262 Ardisia japonica Species 0.000 abstract 1
- 241000130781 Arnebia Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241000520028 Lamium Species 0.000 abstract 1
- 241001479541 Lithospermum erythrorhizon Species 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 241000961922 Onosma Species 0.000 abstract 1
- 240000002924 Platycladus orientalis Species 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 241001448535 Reineckea carnea Species 0.000 abstract 1
- 241000245165 Rhododendron ponticum Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000002912 Salvia officinalis Nutrition 0.000 abstract 1
- 241001369613 Stephania tetrandra Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 210000000994 inner shell membrane Anatomy 0.000 abstract 1
- 235000002020 sage Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 239000002689 soil Substances 0.000 abstract 1
- 239000004071 soot Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 35
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 206010062717 Increased upper airway secretion Diseases 0.000 description 19
- 230000023597 hemostasis Effects 0.000 description 19
- 208000026435 phlegm Diseases 0.000 description 19
- 230000001737 promoting effect Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 16
- 238000001816 cooling Methods 0.000 description 15
- 206010011224 Cough Diseases 0.000 description 14
- 206010017076 Fracture Diseases 0.000 description 14
- 208000010392 Bone Fractures Diseases 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000035619 diuresis Effects 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 7
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000001174 ascending effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020601 Hyperchlorhydria Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000011708 Avulsion fracture Diseases 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960001991 ceftizoxime Drugs 0.000 description 1
- NNULBSISHYWZJU-LLKWHZGFSA-N ceftizoxime Chemical compound N([C@@H]1C(N2C(=CCS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 NNULBSISHYWZJU-LLKWHZGFSA-N 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
| 年龄(岁) | 20~30 | 31~40 | 41~50 | 51~66 |
| 例数 | 13 | 252 | 121 | 6 |
| 百分比 | 3.3% | 64.3% | 30.9% | 1.5% |
| 疗效 | 治愈 | 好转 | 无效 |
| 例数 | 389 | 3 | 无 |
| 百分比 | 99.2% | 0.8% | 无 |
| 治疗天数 | 3~6 | 7~10 | 11~14 | 15~26 |
| 例数 | 21 | 235 | 127 | 9 |
| 百分比 | 5.4% | 59.9% | 32.4% | 2.3% |
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210305123 CN102824562B (zh) | 2012-08-27 | 2012-08-27 | 一种治疗吸烟型闭合性骨折的中药洗剂制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210305123 CN102824562B (zh) | 2012-08-27 | 2012-08-27 | 一种治疗吸烟型闭合性骨折的中药洗剂制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102824562A CN102824562A (zh) | 2012-12-19 |
| CN102824562B true CN102824562B (zh) | 2013-11-06 |
Family
ID=47328008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210305123 Expired - Fee Related CN102824562B (zh) | 2012-08-27 | 2012-08-27 | 一种治疗吸烟型闭合性骨折的中药洗剂制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102824562B (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110920A (zh) * | 1994-04-27 | 1995-11-01 | 马厚泽 | 骨质增生治疗药剂及其配制方法 |
| CN1317319A (zh) * | 2000-04-07 | 2001-10-17 | 吴景林 | 骨伤膏及其制作方法 |
| CN1509756A (zh) * | 2002-12-24 | 2004-07-07 | 潘小红 | 一种治疗脏腑疾病的中草药肾天素 |
-
2012
- 2012-08-27 CN CN 201210305123 patent/CN102824562B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110920A (zh) * | 1994-04-27 | 1995-11-01 | 马厚泽 | 骨质增生治疗药剂及其配制方法 |
| CN1317319A (zh) * | 2000-04-07 | 2001-10-17 | 吴景林 | 骨伤膏及其制作方法 |
| CN1509756A (zh) * | 2002-12-24 | 2004-07-07 | 潘小红 | 一种治疗脏腑疾病的中草药肾天素 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102824562A (zh) | 2012-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102793852B (zh) | 一种治疗发热型闭合性骨折的中药洗剂制备方法 | |
| CN102824622B (zh) | 一种治疗心悸型闭合性骨折的中药洗剂制备方法 | |
| CN102793868B (zh) | 一种治疗喘促型闭合性骨折的中药洗剂制备方法 | |
| CN102824590B (zh) | 一种治疗呼吸作痛型闭合性骨折的中药洗剂制备方法 | |
| CN102824538B (zh) | 一种治疗胃热型闭合性骨折的中药洗剂制备方法 | |
| CN102824421B (zh) | 一种治疗惊惕型闭合性骨折的中药洗剂制备方法 | |
| CN102824523B (zh) | 一种治疗头痛型闭合性骨折的中药洗剂制备方法 | |
| CN102824557B (zh) | 一种治疗搔痒型闭合性骨折的中药洗剂制备方法 | |
| CN102824558B (zh) | 一种治疗呕吐型闭合性骨折的中药洗剂制备方法 | |
| CN102824562B (zh) | 一种治疗吸烟型闭合性骨折的中药洗剂制备方法 | |
| CN102813826B (zh) | 一种治疗疼痛型闭合性骨折的中药洗剂制备方法 | |
| CN102824601B (zh) | 一种治疗肿胀型闭合性骨折的中药洗剂制备方法 | |
| CN102824536B (zh) | 一种治疗肿块型闭合性骨折的中药洗剂制备方法 | |
| CN102824554B (zh) | 一种治疗口渴型闭合性骨折的中药洗剂制备方法 | |
| CN102824561B (zh) | 一种治疗酗酒型闭合性骨折的中药洗剂制备方法 | |
| CN102824571B (zh) | 一种治疗嗜食辣椒型闭合性骨折的中药洗剂制备方法 | |
| CN102824546B (zh) | 一种治疗肾阴亏虚型闭合性骨折的中药洗剂制备方法 | |
| CN102793853B (zh) | 一种治疗便秘型闭合性骨折的中药洗剂制备方法 | |
| CN102824537B (zh) | 一种治疗胃纳呆型闭合性骨折的中药洗剂制备方法 | |
| CN102824540B (zh) | 一种治疗血虚型闭合性骨折的中药洗剂制备方法 | |
| CN102824559B (zh) | 一种治疗肾阳虚型闭合性骨折的中药洗剂制备方法 | |
| CN102813827B (zh) | 一种治疗血尿型闭合性骨折的中药洗剂制备方法 | |
| CN102824585B (zh) | 一种治疗气虚型闭合性骨折的中药洗剂制备方法 | |
| CN102824583B (zh) | 一种治疗腰痛型闭合性骨折的中药洗剂制备方法 | |
| CN102824539B (zh) | 一种治疗灼红紫黑型闭合性骨折的中药洗剂制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG HUI Free format text: FORMER OWNER: JIN XIANLING Effective date: 20130927 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Hui Inventor before: Jin Xianling |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JIN XIANLING TO: WANG HUI Free format text: CORRECT: ADDRESS; FROM: 250200 JINAN, SHANDONG PROVINCE TO: 272111 JINING, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130927 Address after: 272111 the first people's Hospital of Shandong, Jining Applicant after: Wang Hui Address before: 250200 Zhangqiu chronic disease control station, 6 West Ring Road, Zhangqiu, Shandong, Ji'nan Applicant before: Jin Xianling |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 Termination date: 20140827 |
|
| EXPY | Termination of patent right or utility model |